Vision Point Advisory Group, LLC Gilead Sciences, Inc. Transaction History
Vision Point Advisory Group, LLC
- $473 Million
- Q3 2025
A detailed history of Vision Point Advisory Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Vision Point Advisory Group, LLC holds 4,855 shares of GILD stock, worth $602,408. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,855
Previous 4,364
11.25%
Holding current value
$602,408
Previous $483,000
11.39%
% of portfolio
0.11%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,338Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.34 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.75 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.66 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...